PaulAMeyersMD

PubMed

• Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
  Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B Banks, Jason Chan
  Clinical Cancer Research. 2024-12-16
• 2 citations
  Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
  Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis
  Journal of Clinical Oncology. 2024-11-01
• Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.
  Priya H Marathe, Valeria Santibanez, Paul A Meyers, Maria L Padilla, Danielle N Friedman
  Pediatric Blood & Cancer. 2024-07-01

Journal Articles

• Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production.  
  Broxmeyer HE, Smithyman A, Eger RR, Meyers PA, de Sousa M, J Exp Med. 1978 Oct 1;148(4):1052-67
• Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera.  
  Winchester RJ, Meyers PA, Broxmeyer HE, Wang CY, Moore MA, Kunkel HG, J Exp Med. 1978 Aug 1;148(2):613-8
• Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA).  
  Broxmeyer HE, Ralph P, Margolis V, Nakoinz I, Meyers PA, Kapoor N, and Moore MAS., Leukemia Research 1979; 3:193-203
• Cytogenetic evidence for monoclonal origin of acute leukemia in monozygotic twins.  
  Chaganti RSK, Miller DR, Meyers PA, and German JL, New England J Med 1979; 300:1032-1034
• Isolation of pluripotent hematopoietic stem cells and clonable precursor cells of erythrocytes, granulocytes, macrophages, and megakaryocytes from mouse bone marrow.  
  Williams N, Jackson H, and Meyers PA, Exp Hemat 1979; 7:524-534
• Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.  
  Moore MAS, Broxmeyer HE, Sheridan APC, Meyers PA, Jacobsen N, and Winchester RJ, Blood 1980; 55:682-690
• Synthesis and release of erythroid colony- and burst-potentiating activity by purified populations of murine peritoneal macrophages.  
  Kurland JI, Meyers PA, and Moore MAS, J Exp Med 1980; 151:839-852
• Specific inhibitory activity against granulocyte-progenitor cells produced by non-T lymphocytes from patients with neutropenia.  
  Broxmeyer HE, Pahwa R, Jacobsen N, Pelus LM, Ralph P, Meyers PA, Pahwa S, and Kapoor N, Exp Hemat 1980; 8:278-297
• Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.  
  Castro-Malaspina H, Gay RE, Kapoor N, Meyers P, Chiarieri D, McKenzie S,Broxmeyer HE, and Moore MAS, Blood 1980; 56:289-301
• Acute myeloblastic leukemia following non-Hodgkin's lymphoma in an adolescent. A report of a case with preleukemic syndrome, and a review of the literature.  
  Kaur P, Miller DR, Andreeff M, Chaganti R, and Meyers PA, Med Ped Onc 1981; 9:69-80
• Testicular leukaemic infiltrates at diagnosis of acute lymphoblastic leukaemia.  
  Meyers PA and Sorell M, Lancet 1981; ii:984-985
• Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders.  
  Castro-Malaspina H, Gay RE, Jhanwar SC, Hamilton JA, Chiarieri DR, Meyers PA, Gay S, and Moore MAS, Blood 1982; 59:1046-1054
• Primary hepatic or hepato-splenic non-Hodgkin's lymphoma in children.  
  Miller ST, Wollner N, Meyers PA, Exelby P, Jereb B, and Miller DR, Cancer 1983; 52:2285-2288
• Association of cell cycle expression of Ia-like antigenic determinants on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation...  
  Li L, Broxmeyer HE, Meyers PA, Moore MAS and Thaler HT, Blood 1983; 61:250-256
• Hereditary transcobalamin II deficiency with subnormal serum cobalamin levels.  
  Meyers, PA and Carmel R, Pediatrics 1984; 74:866-871
• Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.  
  Broxmeyer HE, Gentile P, Cooper S, Lu L, Juliano L, Piaciebello W, Meyers PA, and Cavanna F, Blood Cells 1984; 10: 397-426
• Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma (NHL).  
  Meyers PA, Potter VP, Wollner N, and Exelby P, Cancer 1985; 56: 259-26l
• Improved disease free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the "New York" regimen - a new intensive therapy proto...  
  Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H, Hammond D, J Clin Onc 1986; 4:744-752
• A group program for helping siblings of children with cancer.  
  Adams-Greenly M, Shminski-Maher T, McGowan N, Meyers PA, J. Psychosoc Onc 1987; 4:55-67
• Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.  
  Tan CTC, Hancock C, Steinherz P, Bacha DM, Steinherz L, Luks E, Winick N, Meyers P, Mondora A, Dantis E, Stevens Y W, Cancer Research 1987; 47:2990-2995
• En bloc surgery for osteogenic sarcoma: Analysis and review of 180 cases.  
  Marcove RC, Huvos AG, Meyers PA, Caparros-Sison B, Rosen G, Dev Oncol. 55:245-249
• Persistent B-19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.  
  Kurtzman GJ, Cohen B, Meyers P, Amunullah A, and Young NS, Lancet 1988; ii:1159-1162
• En bloc surgery for osteogenic sarcoma: analysis and review.  
  Marcove RC, Huvos AG, Meyers PA, Caparros-Sison B, Rosen G, Comprehensive Therapy 14(5):3-6, 1988
• Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.  
  Steinherz P, Meyers P, Wollner N, Redner A, Tan C., Cancer 1989; 63:1472-1476
• Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute non-lymphoblastic leukemia.  
  Meyers PA, Tan CTC, Steinherz PG, Redner A, Cancer 1989; 64:2416-2419
• Join now to see all

Books/Book Chapters

• Birth Defects Encyclopedia. 
  Chapter: Anemia, pernicious congenital 
  Meyers PAEditors: Buyse ML.Blackwell Scientific Publications, Cambridge MA
• Current Treatment Options in Oncology. 
  Chapter: Ewing’s Sarcoma 
  Meyers PA, Levy AS
• Therapy of Cancer in Children. 
  Chapter: Osteosarcoma and Ewing’s Sarcoma 
  Meyers PAEditors: Pratt C, Herzog C.Clinical Insights, New York
• Priniciples and Practice of Pediatric Oncology. 
  Chapter: Osteosarcoma 
  Link MP, Meyers PA, Gebhardt MEditors: Pizzo PA, Poplack DG.Lippincott, Williams, & Wilkins, PhiladelphiaEdition 4,
• Saunders Manual of Pediatric Practice. 
  Chapter: Ewing’s Sarcoma 
  Page 482 - 484Meyers PAEditors: Finberg L.WB Saunders
• Saunders Manual of Pediatric Practice. 
  Chapter: Osteosarcoma 
  Page 480 - 482Meyers PAEditors: Finberg L.WB Saunders
• Saunders Manual of Pediatric Practice. 
  Chapter: Section editor, Hematology/Oncology 
  Page 373 - 492Meyers PAEditors: Finberg L.WB Saunders
• Osteosarcoma in Pediatric Clinics of North America. 
  Page 973 - 989Meyers PA and Gorlick RWB Saunders, Philadelphia
• Blood Diseases of Infancy and Childhood. 
  Chapter: Megaloblastic anemias 
  Page 220 - 240Kamen BA and Meyers PAEditors: Miller DR and Baehner RL.CV Mosby
• Acute Lymphoblastic Leukemia: Current Controversies and Future Direction. 
  Chapter: Improved survival of children with high-risk lymphoblastic leukemia: Report from the Children's Cancer Study and the Memorial Sloan-Kettering "New York" protocols 
  Page 147 - 156Steinherz PG, Gaynon P, Haimi J, Meyers P, Redner A, Steinherz L, Andreeff M, Hammond DEditors: R.P. Gale, D. Hoelzer.Wiley-Liss, New York
• Birth Defects Encyclopedia. 
  Chapter: Transcobalamin II deficiency 
  Page 1693 - 1694Meyers PAEditors: Buyse ML.Blackwell Scientific Publications, Cambridge MA
• Acute Lymphoblastic Leukemia: Current Controversies and Future Direction.. 
  Chapter: Improved survival of children with high-risk lymphoblastic leukemia: Report from the children’s cancer study and the Memorial Sloan-Kettering “New York” protocols 
  Page 1437 - 1456Steinherz PG, Gaynon P, Haimi J, Meyers P, Redner A, Steinherz L, Andreeff M, Hammond DEditors: Gale RP, Hoelzer D.Wiley-Liss, New York
• Blood Diseases of Infancy and Childhood. 
  Chapter: Megaloblastic anemia 
  Page 199 - 220Meyers PAEditors: Miller DR and Baehner RL.CV Mosby
• Hematology-Oncology Clinics of North America. 
  Chapter: Osteogenic sarcoma 
  Page 655 - 665Meyers PAEditors: Pochedly CA.WB Saunders, Philadelphia
• Hematology-Oncology Clinics of North America. 
  Chapter: Ewing’s sarcoma 
  Page 667 - 673Meyers PAEditors: Pochedly CA.WB Saunders, Philadelphia
• Blood Diseases of Infancy and Childhod. 
  Chapter: Megaloblastic anemias 
  Page 147 - 170Meyers PA and Miller DREditors: Miller DR, Baehner RL, McMillian C.CV Mosby, St. LouisEdition 5,
• Hemoglobins in Development and Differentiation. 
  Chapter: Activation of fetal hemoglobin synthesis in cultured adult bone marrow 
  Page 389 - 395Meyers PA, Integlia B, Kapoor N, and Moore MASEditors: Stamatoyannopoulos G and Nienhuis AW.Liss, New York
• Chelation Therapy in Chronic Iron Overload. 
  Chapter: Continuous intravenous and sub-cutaneous deferrioxamine therapy in beta thalassemia major 
  Page 115 - 125Markenson AL, Graziano JH, Miller DR, Chang H, Bestak M, Meyers P, Pisciotta P, Rifkind AEditors: EC Zaino and RH Roberts. Symposia Specialists Inc
• Join now to see all

Lectures

• The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the ... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Other

• High dose therapy with autologous stem cell rescue for pediatric sarcomas. 
  Meyers PA, ASCO Education Book
• Holcombe Grier Faculty of 1000 Medicine: evaluations for Meyers PA et al. 
  Paul A. Meyers, Cindy Schwartz, Mark Krailo, Eugenie Kleinerman, Donna Betcher, William Ferguson, Mark Gebhardt, Allen Goorin, Helen Nadel, Michael Nieder, Gene Sigel,..., J Clin Oncol 2008 Feb 1 26 (4) :633-8
  http://www.f1000medicine.com/article/id/1100377/evaluation
• Response to Osteosarcoma: Time to Move On? 
  Meyers PA, Kleinerman E, European Journal of Cancer
  http://www.ecco-org.eu/News/News/EJC-Correspondence/Latest-Correspondence/Osteosarcoma-Time-to-move-